Rank 62 • Consumer & Prevention
Prenuvo
Offers AI-enhanced whole-body MRI screening scans designed to detect early-stage cancers, aneurysms, and silent health conditions.
Visit website- Signal Score
- 84.9
- Total raised
- $70M
- Stage
- Series C
- Founded
- 2018
- Headquarters
- Redwood City, USA
- Region
- North America
Their signal
Prenuvo has popularized preventative medicine through high consumer visibility, utilizing proprietary AI to accelerate scanning times and improve diagnostic precision at scale.
Signal Score 84.9editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in Consumer & Prevention
Did we miss something?
Change, add or remove details on this company. Our desk reviews every request.
Figures are subjective research desk estimates compiled from public sources and refreshed monthly, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.